SailajaPuttaguntaMD

PubMed

• Sulopenem Disk Development, Quality Control Range, and MIC to Disk Result Correlation forIsolates.
  Sailaja Puttagunta, Steven I Aronin, Jeanna DiFranco-Fisher, Laura Koeth> ;Journal of Clinical Microbiology. 2023 Jul 20
• In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Pr...
  Joshua M Maher, Michael D Huband, Christopher G Blankers, Sailaja Puttagunta, Steven I Aronin, Mariana Castanheira> ;The Journal of Antimicrobial Chemotherapy. 2023 Jun 1
• Applying Desirability of Outcome Ranking End Points.
  Steven I Aronin, Anita F Das, Jayanti Gupta, Karthik Akinapelli, Michael T Zelasky, Sailaja Puttagunta, Helen W Boucher, Dunne, M. W., Michael W Dunne> ;Clinical Infectious Diseases. 2023 Jul 5
• Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections.
  Steven I Aronin, Anita F Das, Jayanti Gupta, Karthik Akinapelli, Jeanne Breen, Michael T Zelasky, Sailaja Puttagunta, Dunne, M. W., Michael W Dunne> ;Clinical Infectious Diseases. 2023 Jun 16
• 7 citations
  Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial.
  Steven I Aronin, Anita F Das, Karthik Akinapelli, Michael T Zelasky, Sailaja Puttagunta, Helen W Boucher, Dunne, M. W., Michael W Dunne> ;Clinical Infectious Diseases. 2023 Jan 6
• 7 citations
  Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial.
  Michael W Dunne, Steven I Aronin, Anita F Das, Karthik Akinapelli, Jeanne Breen, Michael T Zelasky, Sailaja Puttagunta> ;Clinical Infectious Diseases. 2023 Jan 6
• 139 citations
  Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation.
  Sara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas, Denise Kviatcovsky, Eyal Weinstock, Yulia Matiuhin, Yael Silberberg, Koji Atarashi, Munehiro Furuichi, Akihiko Ok...> ;Cell. 2022 Aug 4
• 11 citations
  Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible.
  Sailaja Puttagunta, Steven I Aronin, Stephen Brossette, John Murray, Vikas Gupta, Dunne, M. W., Michael W Dunne> ;Microbiology Spectrum. 2022 Feb 23
• 2 citations
  Outcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials.
  Pedro L Gonzalez, Urania Rappo, Karthik Akinapelli, Jennifer S McGregor, Sailaja Puttagunta, Dunne, M. W., Michael W Dunne> ;Infectious Diseases and Therapy. 2022 Feb 1
• 4 citations
  Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analys...
  Pedro L Gonzalez, Urania Rappo, Veronica Mas Casullo, Karthik Akinapelli, Jennifer S McGregor, Jennifer C. Nelson, Michael Nowak, Sailaja Puttagunta, Dunne, M. W., Mic...> ;Infectious Diseases and Therapy. 2021 Jan 30
• 18 citations
  In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli.
  James A. Karlowsky, Heather J. Adam, Melanie R. Baxter, Andrew J Denisuik, Philippe Lagacé-Wiens, Andrew Walkty, Sailaja Puttagunta, George G. Zhanel, Dunne, M. W., Mi...> ;Antimicrobial Agents and Chemotherapy. 2019 Jan 1
• 12 citations
  Epithelial Lining Fluid and Plasma Concentrations of Dalbavancin in Healthy Adults after a Single 1,500-Milligram Infusion.
  Urania Rappo, Sailaja Puttagunta, James Baldassarre, Shengfang Su, Daksha Desai-Krieger, Megumi Inoue, Dunne, M. W., Michael W. Dunne> ;Antimicrobial Agents and Chemotherapy. 2019 Oct 22
• 19 citations
  Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections
  Urania Rappo, Pedro L Gonzalez, Sailaja Puttagunta, Karthik Akinapelli, Katelyn R. Keyloun, Patrick Gillard, Yan Liu, Michael W. Dunne> ;Journal of Global Antimicrobial Resistance. 2019 Feb 20
• 110 citations
  Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety.
  Urania Rappo, Sailaja Puttagunta, Vadym Shevchenko, Alena Shevchenko, Alena Jandourek, Pedro L Gonzalez, Amy Suen, Veronica Mas Casullo, David Melnick, Rosa Miceli, Mi...> ;Open Forum Infectious Diseases. 2019 Jan 1
• 12 citations
  Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs.
  Pedro L Gonzalez, Urania Rappo, Karthik Akinapelli, Jennifer S McGregor, Sailaja Puttagunta, Dunne, M. W., Michael W. Dunne> ;Drugs in Context. 2018 Dec 11
• 155 citations
  A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection
  Michael W. Dunne, Sailaja Puttagunta, Philip Giordano, Dainis Krievins, Michael Zelasky, James Baldassarre> ;Clinical Infectious Diseases. 2016 Mar 1
• 52 citations
  Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies.
  George H. Talbot, Helen W. Boucher, Mark H. Wilcox, Sailaja Puttagunta, Dunne, M. W., Michael W. Dunne> ;Drug Safety. 2016 Feb 1
• 31 citations
  Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis
  Yoav Barnea, Anat Lerner, Asaf Aizic, Shiri Navon-Venezia, Eleanor Rachi, Sailaja Puttagunta, Yehuda Carmeli, Dunne, M. W., Michael W. Dunne> ;The Journal of Antimicrobial Chemotherapy. 2016 Feb 1
• 13 citations
  Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects.
  Patrick Scoble, Robert C. Owens, Sailaja Puttagunta, Mark Yen, Dunne, M. W., Michael W. Dunne> ;Clinical Drug Investigation. 2015 Oct 12
• 37 citations
  In Vitro Activity of Dalbavancin against Drug-Resistant Staphylococcus aureus Isolates from a Global Surveillance Program
  Sandra P. McCurdy, Ronald N. Jones, Rodrigo E. Mendes, Sailaja Puttagunta, Dunne, M. W., Michael W. Dunne> ;Antimicrobial Agents and Chemotherapy. 2015 Aug 1
• 18 citations
  Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies.
  Dan Sahm, Sailaja Puttagunta, Dunne, M. W., Michael W. Dunne> ;Annals of Clinical Microbiology and Antimicrobials. 2015 Apr 2
• 142 citations
  Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue
  Sailaja Puttagunta, Craig R. Sprenger, Chris Rubino, Scott A. Van Wart, James Baldassarre, Dunne, M. W., Michael W. Dunne> ;Antimicrobial Agents and Chemotherapy. 2015 Apr 1
• 16 citations
  The Ability of Virulence Factor Expression by Pseudomonas aeruginosa to Predict Clinical Disease in Hospitalized Patients
  Michel Ledizet, Thomas S. Murray, Sailaja Puttagunta, Martin D. Slade, Vincent Quagliarello, Barbara I. Kazmierczak> ;Plos One. 2012 Nov 12
• 2 citations
  Cardiac manifestations of HIV.
  Majid Sadigh, Sailaja Puttagunta> ;Frontiers in Bioscience. 2003 May 1
• Join now to see all